Literature DB >> 28930017

Carbapenemase VCC-1-Producing Vibrio cholerae in Coastal Waters of Germany.

Jens A Hammerl, Claudia Jäckel, Valeria Bortolaia, Keike Schwartz, Nadja Bier, Rene S Hendriksen, Beatriz Guerra, Eckhard Strauch.   

Abstract

During antimicrobial drug resistance testing for Vibrio spp. from coastal waters of Germany, we identified 4 nontoxigenic, carbapenem-resistant V. cholerae isolates. We used whole-genome sequencing to identify the carbapenemase gene blaVCC-1. In addition, a molecular survey showed that more blaVCC-1-harboring isolates are present in coastal waters of Germany.

Entities:  

Keywords:  Europe; Germany; Vibrio cholerae; antimicrobial resistance; bacteria; carbapenem resistance; carbapenemase VCC-1; coastal water; environment; multilocus sequence typing; sequence type; whole-genome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28930017      PMCID: PMC5621562          DOI: 10.3201/eid2310.161625

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Mangat et al. recently identified a novel ambler class A carbapenemase (VCC-1) in nontoxigenic Vibrio cholerae isolated from imported retail shrimp from India intended for human consumption in Canada (). Occurrence of blaVCC-1–harboring bacteria in seafood might be caused by uptake of V. cholerae in the aquatic environment. Lutz et al. reported worldwide distribution of V. cholerae non–O1/O139 strains in coastal waters with low salinity (). Some of these strains were associated with wound infections and with diarrheal diseases after ingestion of contaminated seafood (,). An antimicrobial resistance survey of potentially pathogenic Vibrio spp. recovered from coastal waters of Germany identified 4 carbapenem-resistant V. cholerae non–O1/O139 isolates (). These isolates were detected in the Baltic Sea (VN-2997, Eckernförde) and North Sea (VN-2808, Büsum; VN-2825, Speicherkoog; VN-2923, unknown). We used whole-genome sequencing to examine the genetic basis of carbapenem resistance in these strains. We isolated genomic DNA by using the Easy-DNA Kit (Invitrogen, Carlsbad, CA, USA). This DNA was used for preparation of libraries by using the Nextera-XT-DNA Sample Preparation Kit (Illumina Inc., San Diego, CA, USA) and sequenced by using an MiSeq-benchtop-sequencer, MiSeq-Reagent version 2 (300 cycles), and two 150-bp paired-end reads (Illumina Inc.). We then performed de novo assemblies of reads by using SPAdes version 3.5.0 (http://spades.bioinf.spbau.ru/release3.5.0/manual.html). We deposited sequences in GenBank (Table) and preformed genome annotation by using the NCBI Prokaryotic Genome Annotation Pipeline (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/).
Table

Genome characteristics of 4 carbapenemase-producing Vibrio cholerae isolates from coastal waters of Germany*

CharacteristicIsolate
VN-2808VN-2825VN-2923VN-2997
No. genes3,9343,9214,0403,933
Coding genes3,5453,6083,6503,612
No. CDS 3,8133,8033,9203,814
Coding CDS3,5453,6083,6503,612
No. RNA genes121118120119
No. rRNAs (5S, 16S, 23S)10, 12, 710, 12, 410, 11, 710, 12, 4
Complete rRNAs (5S, 23S)10, 110, 110, 110, 1
Partial rRNAs (16S, 23S)12, 612, 311, 612, 3
No. tRNAs88888889
No. noncoding RNAs 4444
No. pseudogenes268195270202
Ambiguous residues0000
Frameshifted39374037
Incomplete220144221152
Internal stop20252223
Multiple problems11111310
No. predicted prophages5252
Intact2010
Incomplete3142
Questionable0100
No. plasmidsNDNDNDND
Antibiotic resistance
β-lactam†blaVCC-1 (100%)blaVCC-1 (100%)blaVCC-1 (100%)blaVCC-1 (100%)
MLST typeST336ST336ST336ST336
GenBank information
Bioproject no.PRJNA331077PRJNA331078PRJNA331079PRJNA331080
Biosample no.SAMN05437226SAMN0537225SAMN0537224SAMN0537223
Accession no.MCBB00000000MCBA00000000MCAZ00000000MCAY00000000

*In silico analyses were conducted by using the services of the NCB Prokaryotic Genome Annotation Pipeline (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/), the Center for Genomic Epidemiology (http://.genomicepidemiology.org), and PHAST (http://www.phast.wishartlab.com/).CDS, coding DNA sequence; MLST, multilocus sequencing typing; ND, not determined; ST, sequence type.
†Percentage values indicate level of nucleotide similarity against the reference gene (GenBank accession no. KT818596).

*In silico analyses were conducted by using the services of the NCB Prokaryotic Genome Annotation Pipeline (https://www.ncbi.nlm.nih.gov/genome/annotation_prok/), the Center for Genomic Epidemiology (http://.genomicepidemiology.org), and PHAST (http://www.phast.wishartlab.com/).CDS, coding DNA sequence; MLST, multilocus sequencing typing; ND, not determined; ST, sequence type.
†Percentage values indicate level of nucleotide similarity against the reference gene (GenBank accession no. KT818596). We found blaVCC-1 in all isolates on contigs of 2,135 bp (VN-2825, VN-2997), 2,139 bp (VN-2923), and 2,737 bp (VN-2808). The blaVCC-1-coding sequences and flanking nucleotide sequences were 100% identical among the strains, as determined by sequence alignments. We also identified the main characteristics of V. cholerae genomes (Table; Technical Appendix Figure). Overall, the genomes belong to the same multilocus sequence type (ST), ST336 (adk 57, gyrB 76, mdh 14, metE 115, pntA 18, purM 1, pyrC 101) (). We performed functional studies of the entire blaVCC-1–harboring region (pVCC-1C, 2.7 kb) and blaVCC-1 gene (pVCC-1G, 0.9 kb) of V. cholerae VN-2808 (Technical Appendix Figure) by molecular cloning of PCR-amplified regions according to standard procedures (). After transformation of Escherichia coli GeneHogs (Invitrogen, Darmstadt, Germany) and susceptibility testing for aztreonam, imipenem, and meropenem as described (), both constructs showed decreased inhibition zone diameters compared with that for E. coli GeneHogs vector. We observed slightly reduced drug susceptibility levels or intermediate resistance levels, as observed in V. cholerae VN-2808 (Technical Appendix Figure). On the basis of these results, we conducted blaVCC-1 screening of the V. cholerae collection at the German Federal Institute for Risk Assessment (Berlin, Germany). This collection contains 312 toxigenic and nontoxigenic isolates from human, environmental, and food origin obtained in Europe (n = 218), Africa (n = 20), Asia (n = 18), North America (n = 1), South America (n =1), and of unknown origin (n = 54) during 1941–2015. We performed PCR by using primers (blaVCC-1-forward/reverse: 5′-ATCTCTACTTCAACAGCTTTCG/CCTAGCTGCTTTAGCAATCAC-3′) with denaturation at 94°C for 120 s; 35 cycles of denaturation at 94°C for 15 s, annealing at 53°C for 30 s, and elongation for 210 s at 72°C; and a final elongation at 72°C for 1 min. This testing detected blaVCC-1 in 3 (1.6%) ctx-negative, non–O1/O139 V. cholerae isolates obtained from waters of the port of Husum, Germany, on the North Sea during 2015. Sanger sequencing confirmed the presence of blaVCC-1. These 3 isolates belong to the new multilocus ST516. This type is divergent from ST336 only for the novel pyrC 150 variant, which was recently deposited in the PubMLST database (https://pubmlst.org). In conclusion, this study showed the presence of 7 VCC-1 carbapenemase-producing V. cholerae at different locations on the coastline of Germany. The blaVCC-1 flanking genetic sequences were identical in the 4 sequenced V. cholerae from Germany and appeared to be different from the strain isolated in Canada, which probably originated in India (Technical Appendix Figure). This finding suggests that blaVCC-1 was acquired by V. cholerae from a yet unknown progenitor on at least 2 occasions. Strains from Germany probably belong to the autochthonous microflora and represent an environmental reservoir of carbapenem resistance in coastal waters. blaVCC-1–encoding V. cholerae might be taken up by mussels, shrimps, and fish and then enter the food chain. Because carbapenems are needed for treatment of severe infections with multidrug-resistant bacteria in humans, the presence of bacteria with acquired, and thereby potentially transferable, carbapenemases in environments near human activities is a major public health concern (). To date, acquired carbapenemases were detected mainly in clinical isolates and only rarely in environmental and foodborne bacteria (,). Exposure of humans to carbapenemase-producing pathogenic bacteria by ingestion of contaminated food products or by direct contact with contaminated water might pose a threat to public health. Our findings indicate that surveillance for antimicrobial drug resistance should be extended to locations of human activities and foods of aquatic origin.

Technical Appendix

Additional information on carbapenemase VCC-1–producing Vibrio cholerae in coastal waters of Germany.
  8 in total

Review 1.  Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options.

Authors:  Shio-Shin Jean; Wen-Sen Lee; Carlos Lam; Chin-Wang Hsu; Ray-Jade Chen; Po-Ren Hsueh
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 2.  Vibrio cholerae non-O1 bacteraemia: description of three cases in the Netherlands and a literature review.

Authors:  Madelon F Engel; Mariette A Muijsken; Esther Mooi-Kokenberg; Ed J Kuijper; David J van Westerloo
Journal:  Euro Surveill       Date:  2016-04-14

Review 3.  Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?

Authors:  Neil Woodford; David W Wareham; Beatriz Guerra; Christopher Teale
Journal:  J Antimicrob Chemother       Date:  2013-10-03       Impact factor: 5.790

4.  Characterization of VCC-1, a Novel Ambler Class A Carbapenemase from Vibrio cholerae Isolated from Imported Retail Shrimp Sold in Canada.

Authors:  Chand S Mangat; David Boyd; Nicol Janecko; Sarah-Lynn Martz; Andrea Desruisseau; Michael Carpenter; Richard J Reid-Smith; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2016-01-11       Impact factor: 5.191

5.  BIGSdb: Scalable analysis of bacterial genome variation at the population level.

Authors:  Keith A Jolley; Martin C J Maiden
Journal:  BMC Bioinformatics       Date:  2010-12-10       Impact factor: 3.169

Review 6.  Environmental reservoirs and mechanisms of persistence of Vibrio cholerae.

Authors:  Carla Lutz; Martina Erken; Parisa Noorian; Shuyang Sun; Diane McDougald
Journal:  Front Microbiol       Date:  2013-12-16       Impact factor: 5.640

7.  Non-O1, non-O139 Vibrio cholerae bacteraemia: case report and literature review.

Authors:  S Deshayes; C Daurel; V Cattoir; J-J Parienti; M-L Quilici; A de La Blanchardière
Journal:  Springerplus       Date:  2015-10-05

8.  Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters.

Authors:  Nadja Bier; Keike Schwartz; Beatriz Guerra; Eckhard Strauch
Journal:  Front Microbiol       Date:  2015-10-28       Impact factor: 5.640

  8 in total
  7 in total

1.  Molecular Basis for the Potent Inhibition of the Emerging Carbapenemase VCC-1 by Avibactam.

Authors:  Chand S Mangat; Grishma Vadlamani; Viktor Holicek; Mitchell Chu; Veronica L C Larmour; David J Vocadlo; Michael R Mulvey; Brian L Mark
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Vibrios from the Norwegian marine environment: Characterization of associated antibiotic resistance and virulence genes.

Authors:  Fredrik Håkonsholm; Bjørn Tore Lunestad; Jose Roberto Aguirre Sánchez; Jaime Martinez-Urtaza; Nachiket Prakash Marathe; Cecilie Smith Svanevik
Journal:  Microbiologyopen       Date:  2020-06-17       Impact factor: 3.139

3.  Genomic and Resistance Epidemiology of Gram-Negative Bacteria in Africa: a Systematic Review and Phylogenomic Analyses from a One Health Perspective.

Authors:  John Osei Sekyere; Melese Abate Reta
Journal:  mSystems       Date:  2020-11-24       Impact factor: 6.496

4.  Draft Genome Sequences of Vibrio cholerae Non-O1, Non-O139 Isolates from Common Tern Chicks (Sterna hirundo) following a Mass Mortality Event.

Authors:  Eckhard Strauch; Claudia Jäckel; Jens Andre Hammerl; Veit Hennig; Nicole Roschanski; Insa Dammann
Journal:  Microbiol Resour Announc       Date:  2020-11-12

5.  Complete Genome Sequence of a blaCTX-M-1-Harboring Escherichia coli Isolate Recovered from Cattle in Germany.

Authors:  Jens A Hammerl; Alexandra Irrgang; Mirjam Grobbel; Bernd-Alois Tenhagen; Annemarie Käsbohrer
Journal:  Genome Announc       Date:  2018-01-25

6.  Molecular Analysis of Selected Resistance Determinants in Diarrheal Fecal Samples Collected From Kolkata, India Reveals an Abundance of Resistance Genes and the Potential Role of the Microbiota in Its Dissemination.

Authors:  Rituparna De; Asish Kumar Mukhopadhyay; Shanta Dutta
Journal:  Front Public Health       Date:  2020-03-11

7.  Vibrio Species in an Urban Tropical Estuary: Antimicrobial Susceptibility, Interaction with Environmental Parameters, and Possible Public Health Outcomes.

Authors:  Anna L B Canellas; Isabelle R Lopes; Marianne P Mello; Rodolfo Paranhos; Bruno F R de Oliveira; Marinella S Laport
Journal:  Microorganisms       Date:  2021-05-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.